As of August 28, 2026, Basel Medical Group Ltd (BMGL) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Basel Medical Group Ltd has a market capitalization of $11.16M, 18.79M shares outstanding, 5 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.63 below $1 exchange minimum
Market Data
Market Cap$11.16M
Shares Outstanding18.79M
Float6.02M
Cash$7.69M
Debt$5.11M
Short InterestN/A
Institutional Holdings
QoQ: ↓ 11.5% shares (2026Q1 vs prior)
5 institutional holders · 128.2K shares
#1
MORGAN STANLEY
74.3K shares
#2
XTX Topco Ltd
25.8K shares
#3
T3 Companies, LLC
15.0K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest15.7K
Days to Cover2.1
% of Float0.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track BMGL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BMGL — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for BMGL
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.